US Patent Number
10,288,626
Publication Date
5-14-2019
Abstract
Disclosed herein are methods for detecting Pgrmc 1 in bodily fluids, e.g., blood, plasma and serum, wherein detection of Pgrmcl is a biomarker for the presence of cancer, e.g., lung cancer or head or neck cancer. Pgrmc 1 levels in bodily fluids may be used to predict patient prognosis, e.g., survival and response to therapy.
Assignees
University of Kentucky Research Foundation, Lexington, KY, (US)
Application Number
14/028,224
Filing Date
09/16/2013
Recommended Citation
Craven, Rolf Joseph, "Secreted Tumor-Associated Cytochrome as a Blood-Based Biomarker for Cancer" (2019). Pharmacology and Nutritional Sciences Faculty Patents. 53.
https://uknowledge.uky.edu/pharmacol_patents/53
